leisure time -WSS

leisure time

author：explore 2025-10-01 18:33:59 - browse：86

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FTC falls short on scrutinizing hospital mergers, study says

focus

explore

WSS

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Why getting cancer drugs just got harder for rural patients

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

FTC falls short on scrutinizing hospital mergers, study says

Scientists unlock the key to scar

Cancer researcher Catriona Jamieson is sending tumors into space

hotspot

leisure time

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

International team creates first chimeric human

Medicare details structure of new drug price negotiation program

Scientists unlock the key to scar

Anesthesiologist group: stop taking Ozempic before surgery

Why rehabilitation engineers need to center patients in their research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

An inside look at PIPEs, biotech's buzzy new financing tool

State Dept. review finds Biden bears some blame for Afghanistan failures

FTC falls short on scrutinizing hospital mergers, study says

Wikipedia

Bird flu in milk supply is likely coming from asymptomatic cows

Key Senate committee drafts bipartisan bill to stem drug shortages

Why does health care cost so much? A reading guide

Cue Health's Covid

Biotech companies concerned about China biosecurity crackdown

Obesity now affects over 1 billion people worldwide, study finds

Wikipedia

focus

explore

focus